Association Between Tic Aggravation and Methylphenidate in Youth With Attention-Deficit/Hyperactivity Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective This study aimed to determine the tic aggravation event rate and cumulative incidence rate in the use of methylphenidate (MPH) treatment in attention-deficit/hyperactivity disorder (ADHD) and the factors that influence tic aggravation.Methods We conducted a retrospective chart review of children and adolescents aged between 6 to 15 years, who were diagnosed with ADHD from January 2017 to December 2019. A total of 121 subjects were included. The MPH dosage, psychiatric family history, comorbidity and past history of tics were assessed through chart review and the psychological examinations data were included. Collected data were analyzed using Cox regression and Kaplan-Meier survival analysis.Results Tic aggravation event rates without a past history of tics were 2.9% with MPH treatment in ADHD. Past history of tics, total MPH dosage and age were the factors associated with tic aggravation ([HR 21.46, p<0.001], [HR 0.94, p=0.023], [HR 0.79, p=0.021] for each). Cumulative incidence of tic aggravation was different between groups with or without past tic history. When treated with MPH, all tic aggravation appeared within approximately eight months but for subjects with a past history of tic, aggravation showed within approximately six months (p<0.001).Conclusion Tic aggravation event rate was significantly low especially in the group without a past history of tics with the use of MPH in ADHD. However, a thorough assessment of past history of tics, and close monitoring during the first six-eight months of treatment with MPH is needed to avert a potential worsening of tics.
Abstract
Objective This study aimed to determine the tic aggravation event rate and cumulative incidence rate in the use of methylphenidate (MPH) treatment in attention-deficit/hyperactivity disorder (ADHD) and the factors that influence tic aggravation.Methods We conducted a retrospective chart review of children and adolescents aged between 6 to 15 years, who were diagnosed with ADHD from January 2017 to December 2019. A total of 121 subjects were included. The MPH dosage, psychiatric family history, comorbidity and past history of tics were assessed through chart review and the psychological examinations data were included. Collected data were analyzed using Cox regression and Kaplan-Meier survival analysis.Results Tic aggravation event rates without a past history of tics were 2.9% with MPH treatment in ADHD. Past history of tics, total MPH dosage and age were the factors associated with tic aggravation ([HR 21.46, p<0.001], [HR 0.94, p=0.023], [HR 0.79, p=0.021] for each). Cumulative incidence of tic aggravation was different between groups with or without past tic history. When treated with MPH, all tic aggravation appeared within approximately eight months but for subjects with a past history of tic, aggravation showed within approximately six months (p<0.001).Conclusion Tic aggravation event rate was significantly low especially in the group without a past history of tics with the use of MPH in ADHD. However, a thorough assessment of past history of tics, and close monitoring during the first six-eight months of treatment with MPH is needed to avert a potential worsening of tics.
참고문헌 (31)
- Feldman HM, "Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents", N Engl J Med, 370, pp.838~846 (2014)
- Felt BT, "Diagnosis and management of ADHD in children", Am Fam Physician, 90, pp.456~464 (2014)
- Floet AM, "Attention-deficit", hyperactivity disorder, 2010, pp.31, 56~69
- Gabbard GO, "Treatments of Psychiatric Disorders" (1995), American Psychiatric Association
- Spencer T, "Disentangling the overlap between Tourette’s disorder and ADHD", J Child Psychol Psychiatry, 39, pp.1037~1044 (1998)
- Bawden HN, "Peer relationship problems in children with Tourette’s disorder or diabetes mellitus", J Child Psychol Psychiatry, 39, pp.663~668 (1998)
- Cavanna AE, "The behavioral spectrum of Gilles de la Tourette syndrome", J Neuropsychiatry Clin Neurosci, 21, pp.13~23 (2009)
- Osland ST, "Pharmacological treatment for attention deficit hyperactivity disorder(ADHD)in children with comorbid tic disorders", Cochrane Database Syst Rev, 6, pp.Cd007990~ (2018)
- Wolraich M, "ADHD : clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit", hyperactivity disorder in children and adolescents, 2011, pp.128, 1007~1022
- Cohen SC, "Meta-analysis : risk of tics associated with psychostimulant use in randomized, placebo-controlled trials", J Am Acad Child Adolesc Psychiatry, 54, pp.728~736 (2015)
- Bloch MH, "Metaanalysis : treatment of attention-deficit", hyperactivity disorder in children with comorbid tic disorders, 2009, pp.48, 884~893
- Leckman JF, "Tourette’s syndrome", Lancet, 360, pp.1577~1586 (2002)
- Robertson MM, "Tourette syndrome, associated conditions and the complexities of treatment", Brain, 123, pp.425~462 (2000)
- Mills S, "A guide to childhood motor stereotypies, tic disorders and the tourette spectrum for the primary care practitioner", Ulster Med J, 83, pp.22~30 (2014)
- 소유경, "한국어판 부모, 교사 ADHD 평가 척도의 신뢰도와 타당도 연구", 신경정신의학, 41(2), pp.283~289 (2002), 대한신경정신의학회
- Simonoff E, "Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability", J Child Psychol Psychiatry, 54, pp.527~535 (2013)
- Aman MG, "Methylphenidate treatment in children with borderline IQ and mental retardation : analysis of three aggregated studies", J Child Adolesc Psychopharmacol, 13, pp.29~40 (2003)
- Coutton C, "Array-CGH in children with mild intellectual disability : a populationbased study", Eur J Pediatr, 174, pp.75~83 (2015)
- "Arch Pediatr", 2002, 709~725
- Pringsheim T, "Practice guideline recommendations summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders", Neurology, 92, pp.896~906 (2019)
- Gaub M, "Gender differences in ADHD : a meta-analysis and critical review", J Am Acad Child Adolesc Psychiatry, 36, pp.1036~1045 (1997)
- Hallett M, "Tourette Syndrome : Update", Brain Dev, 37, pp.651~655 (2015)
- Nøvik TS, "Influence of gender on attention-deficit", hyperactivity disorder in Europe--ADORE, 2006, pp.15(Suppl1), I15~I24
- Ramtekkar UP, "Sex and age differences in attention-deficit", hyperactivity disorder symptoms and diagnoses : implications for DSM-V and ICD-11, 2010, pp.49, 217~228
- Willcutt EG, "The prevalence of DSM-IV attention-deficit", hyperactivity disorder : a meta-analytic review, 2012, pp.9, 490~499
- Andersen SL, "Stimulants and the developing brain", Trends Pharmacol Sci, 26, pp.237~243 (2005)
- Gadow KD, "Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder", J Am Acad Child Adolesc Psychiatry, 46, pp.840~848 (2007)
- Jankovic J, "Tourette syndrome : evolving concepts", Mov Disord, 26, pp.1149~1156 (2011)
- Banaschewski T, "Attention-Deficit", Hyperactivity Disorder, 2017, pp.114, 149~159
- Reale L, "Comorbidity prevalence and treatment outcome in children and adolescents with ADHD", Eur Child Adolesc Psychiatry, 26, pp.1443~1457 (2017)
- Bloch MH, "Clinical course of Tourette syndrome", J Psychosom Res, 67, pp.497~501 (2009)